相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma
Anthony J. Scholer et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Potential Impact of Take the Volume Pledge'' on Access and Outcomes for Gastrointestinal Cancer Surgery
Ryan C. Jacobs et al.
ANNALS OF SURGERY (2019)
Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014
Farhad Islami et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET (2019)
Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study
Tara R. Semenkovich et al.
ANNALS OF THORACIC SURGERY (2019)
Association of Discretionary Hospital Volume Standards for High-risk Cancer Surgery With Patient Outcomes and Access, 2005-2016
Kyle H. Sheetz et al.
JAMA SURGERY (2019)
Accuracy of endoscopic ultrasound in esophageal cancer staging
Timothy Krill et al.
JOURNAL OF THORACIC DISEASE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus
Scott M. Atay et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
Predictors of pathologic upstaging in early esophageal adenocarcinoma: Results from the national cancer database
Craig S. Brown et al.
AMERICAN JOURNAL OF SURGERY (2018)
Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes
Adan Z. Becerra et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma
Arianna Barbetta et al.
ANNALS OF THORACIC SURGERY (2018)
Role of neoadjuvant chemoradiotherapy in clinical T2NOMO esophageal cancer: A population-based cohort study
Lucas Goense et al.
EJSO (2018)
The Epidemiology of Esophageal Adenocarcinoma
Helen G. Coleman et al.
GASTROENTEROLOGY (2018)
Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Rossella Reddavid et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer A Propensity Score-Matched Analysis
Ali A. Mokdad et al.
JAMA ONCOLOGY (2018)
Loco-regional staging accuracy in oesophageal cancer-How good are we in the modern era?
David Bunting et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer
Bryan M. Burt et al.
ANNALS OF SURGERY (2017)
Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation
Emmanuel Gabriel et al.
JAMA SURGERY (2016)
Pledging to Eliminate Low-Volume Surgery
David R. Urbach
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Reliability Adjustment for Reporting Hospital Outcomes With Surgery
Justin B. Dimick et al.
ANNALS OF SURGERY (2012)
Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging DISCUSSION
Jennifer Q. Zhang et al.
ANNALS OF THORACIC SURGERY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
分享论文
